EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Casein Kinase 1δ as a Novel Therapeutic Strategy for Amyotrophic Lateral Sclerosis: A Theoretical Study

Albert Gabriel Turpo-Peqqueña iD, Renato Javier Valencia-Arce iD, Fabio Leonardo Del-Carpio-Carrazco iD, David Jonatan Quispe-Ppacco iD, Pierina Fernanda Carbajal-Llerena iD, Harlly Romed Loza-Chipa iD, Antonella Sofia Vásquez-Macedo iD, Badhin Gómez iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262010188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Albert Gabriel Turpo-Peqqueña und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Ingeniería Molecular-CIIM, Universidad Católica de Santa María, Urb. San José s/n, Umacollo, Arequipa 04013, Peru. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Casein Kinase Idelta, Protein Kinase Inhibitors. Die Arbeit nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disease characterized by the degeneration of motor neurons and the pathological accumulation of phosphorylated TDP-43. Casein kinase one delta (CK1δ) has been identified as a key regulator of this aberrant phosphorylation, making it a promising therapeutic target. In this theoretical study, 26 structurally diverse compounds were evaluated against CK1δ using molecular docking, molecular dynamics simulations, and binding free energy calculations. Among them, BZH exhibited the most stable interaction with CK1δ (−46.53±1.94 kcal/mol). An inverse correlation was observed between theoretical affinity and experimental IC50 values, supporting the predictive validity of the computational approach. Pharmacokinetic analysis indicated that IMF and BIP show good oral absorption and the ability to cross the blood–brain barrier. At the same time, the toxicological profile classified all compounds in toxicity Class IV (moderate risk). Additionally, dynamic migration toward an alternative pocket was observed during simulation, highlighting the importance of considering protein flexibility in drug design. This study proposes BZH, IMF, and BIP as promising CK1δ inhibitors for future experimental validation in the treatment of ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisCasein Kinase IdeltaProtein Kinase InhibitorsMolecular Docking SimulationHumansMolecular Dynamics SimulationProtein Binding

Stichwörter der Autor:innen

CK1δMMPBSAamyotrophic lateral sclerosis (ALS)molecular dockingmolecular dynamicsneurodegenerationvirtual screening

Substanzen

Casein Kinase IdeltaProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Centro de Investigación en Ingeniería Molecular-CIIM, Universidad Católica de Santa María, Urb. San José s/n, Umacollo, Arequipa 04013, Peru.
  • Facultad de Medicina Humana, Centro de Investigación y Estudios Médicos (CIEM), Universidad Católica de Santa María, Urb. San José s/n, Arequipa 04013, Peru.
  • Facultad de Biología, Universidad Nacional de San Agustín, Av. Alcides Carrión s/n, Arequipa 04000, Peru.
  • Facultad de Ciencias Farmacéuticas, Bioquímicas y Biotecnológicas, Universidad Católica de Santa María, Urb. San José s/n, Umacollo, Arequipa 04013, Peru.

ORCID-Profile: Albert Gabriel Turpo-Peqqueña, Renato Javier Valencia-Arce, Fabio Leonardo Del-Carpio-Carrazco, David Jonatan Quispe-Ppacco, Pierina Fernanda Carbajal-Llerena, Harlly Romed Loza-Chipa, Antonella Sofia Vásquez-Macedo, Badhin Gómez

Zitieren

APA

Turpo-Peqqueña, A. G., Valencia-Arce, R. J., Del-Carpio-Carrazco, F. L., Quispe-Ppacco, D. J., Carbajal-Llerena, P. F., Loza-Chipa, H. R., Vásquez-Macedo, A. S., & Gómez, B. (2025). Inhibition of Casein Kinase 1δ as a Novel Therapeutic Strategy for Amyotrophic Lateral Sclerosis: A Theoretical Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010188

Vancouver

Turpo-Peqqueña AG, Valencia-Arce RJ, Del-Carpio-Carrazco FL, Quispe-Ppacco DJ, Carbajal-Llerena PF, Loza-Chipa HR, et al. Inhibition of Casein Kinase 1δ as a Novel Therapeutic Strategy for Amyotrophic Lateral Sclerosis: A Theoretical Study. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010188

BibTeX
@article{TurpoPeqquea2025,
  author = {Turpo-Peqqueña, Albert Gabriel and Valencia-Arce, Renato Javier and Del-Carpio-Carrazco, Fabio Leonardo and Quispe-Ppacco, David Jonatan and Carbajal-Llerena, Pierina Fernanda and Loza-Chipa, Harlly Romed and Vásquez-Macedo, Antonella Sofia and Gómez, Badhin},
  title = {Inhibition of Casein Kinase 1δ as a Novel Therapeutic Strategy for Amyotrophic Lateral Sclerosis: A Theoretical Study},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262010188}
}
Kostenlos starten →